John Overdeck’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.6M Sell
443,775
-742,939
-63% -$8M ﹤0.01% 1878
2026
Q1
$10M Sell
1,186,714
-72,317
-6% -$791K 0.01% 1401
2025
Q4
$14.2M Buy
1,259,031
+459,431
+57% +$5.69M 0.02% 906
2025
Q3
$12M Buy
799,600
+725,969
+986% +$10.6M 0.02% 855
2025
Q2
$1.04M Buy
73,631
+4,508
+7% +$80.3K ﹤0.01% 2220
2025
Q1
$1.66M Sell
69,123
-11,740
-15% -$414K ﹤0.01% 1863
2024
Q4
$3.02M Sell
80,863
-199,902
-71% -$9.33M 0.01% 1433
2024
Q3
$14M Sell
280,765
-57,225
-17% -$2.23M 0.03% 622
2024
Q2
$11.7M Buy
337,990
+192,663
+133% +$7.62M 0.03% 654
2024
Q1
$7.95M Sell
145,327
-202,734
-58% -$10M 0.02% 743
2023
Q4
$14.9M Buy
348,061
+339,961
+4,197% +$10.6M 0.03% 523
2023
Q3
$211K Sell
8,100
-50,274
-86% -$1.04M ﹤0.01% 2624
2023
Q2
$1.4M Buy
+58,374
New +$1M ﹤0.01% 1745

Other funds holding BHVN

John Overdeck's BHVN Position: Q2 2026 in Review

John Overdeck reduced its Biohaven (BHVN) stake by 63% in Q2 2026, selling an estimated $8M and leaving 443,775 shares worth $6.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

John Overdeck first reported a position in BHVN in Q2 2023 and has held it in 13 quarters since. The position peaked at $14.9M in Q4 2023. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • John Overdeck held 443,775 shares of Biohaven worth $6.6M as of Q2 2026.
  • John Overdeck sold 742,939 Biohaven shares in Q2 2026, an estimated $8M.
  • Biohaven made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #1878 holding.
  • John Overdeck first reported a position in Biohaven in Q2 2023 and has held it in 13 quarters since.
  • John Overdeck's Biohaven position peaked at $14.9M in Q4 2023.
  • 291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.